SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Arcturus Therapeutics Reports Third-Quarter 2026 Financial Results

Arcturus Therapeutics announced results for the quarter ended September 30, 2026, and provided corporate updates.

ARCT

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, NASDAQ:ARCT), a messenger RNA medicines company focused on the development of liver and respiratory therapeutics, today announced its financial results for the quarter ended September 30, 2026, and provided corporate updates.“The third…

Related stories